T18H9.11

Caenorhabditis elegans

Is affected by adr-1; pals-22; and pals-17 based on RNA-seq studies.

C08H9.18

Caenorhabditis elegans

Is affected by adr-1; etr-1; and pals-25 based on RNA-seq studies.

F28B1.11

Caenorhabditis elegans

Is affected by clk-1 and pals-17 based on microarray and RNA-seq studies.

R07C3.17

Caenorhabditis elegans

Is affected by cpl-1; pals-17; and ilc-17.1 based on RNA-seq studies. Is affected by Tamoxifen and Doxorubicin based on RNA-seq studies.

T28F4.8

Caenorhabditis elegans

Enriched in ADFL based on single-cell RNA-seq studies. Is affected by raga-1; csr-1; and pals-17 based on RNA-seq studies. Is affected by resveratrol based on microarray studies.

B0334.20

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by several genes including sir-2.1; adr-1; and pals-22 based on RNA-seq and microarray studies. Is affected by resveratrol based on microarray studies.

gld-4

Caenorhabditis elegans

Enables poly(A) RNA polymerase activity. Involved in cytosolic mRNA polyadenylation and positive regulation of meiotic cell cycle. Located in P granule. Expressed in Z2; Z3; and germ line. Is an ortholog of human TENT4A (terminal nucleotidyltransferase 4A) and TENT4B (terminal nucleotidyltransferase 4B).